127 related articles for article (PubMed ID: 3298407)
21. Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
La Banda F; Ruiz Moreno M; Carreño V; Bartolome J; Gutiez J; Ramon y Cajal S; Moreno A; Mora I; Carlos Porres J
Lancet; 1988 Jan; 1(8579):250. PubMed ID: 2893078
[No Abstract] [Full Text] [Related]
22. Spontaneous loss of HBeAg and the prevalence of HTLV-III/LAV infection in a cohort of homosexual hepatitis B virus carriers and the implications for antiviral therapy.
Weller IV; Brown A; Morgan B; Hawkins A; Briggs M; Waite J; Cameron CH; Tedder R
J Hepatol; 1986; 3 Suppl 2():S9-16. PubMed ID: 3298414
[TBL] [Abstract][Full Text] [Related]
23. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
24. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
[TBL] [Abstract][Full Text] [Related]
25. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
Brook MG; Karayiannis P; Thomas HC
Hepatology; 1989 Nov; 10(5):761-3. PubMed ID: 2680866
[TBL] [Abstract][Full Text] [Related]
26. A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. Preliminary results.
Barbara L; Mazzella G; Baraldini M; Gasbarrini G; Giungi F; Malavolti M; Mastroroberto L; Miglio F; Roda E; Raise E
J Hepatol; 1986; 3 Suppl 2():S235-8. PubMed ID: 3298411
[No Abstract] [Full Text] [Related]
27. Treatment of chronic viral hepatitis.
Marcellin P; Benhamou JP
Baillieres Clin Gastroenterol; 1994 Jun; 8(2):233-53. PubMed ID: 7949457
[TBL] [Abstract][Full Text] [Related]
28. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
Giacchino R; Facco F; Giambartolomei G; Navone C; Timitilli A; Cirillo C; Barigione G; Terragna A
Chemioterapia; 1988 Dec; 7 Suppl 3():20-5. PubMed ID: 3073870
[TBL] [Abstract][Full Text] [Related]
29. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
[No Abstract] [Full Text] [Related]
30. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
[TBL] [Abstract][Full Text] [Related]
31. Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency virus.
Porres JC; Carreño V; Mora I; Gutiez J; Moreno A; Ramon y Cajal S; Marron JA; Bartolomé J
Hepatogastroenterology; 1988 Dec; 35(6):300-3. PubMed ID: 3215626
[TBL] [Abstract][Full Text] [Related]
32. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
Kay MH; Wyllie R; Deimler C; Caulfield M; Steffen R; Baetz-Greenwalt B
J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507
[TBL] [Abstract][Full Text] [Related]
33. Acyclovir, oral, intravenous and combined with interferon for chronic HBeAg-positive hepatitis.
Schalm SW; Heytink RA; Van Buuren HR; De Man RA
J Hepatol; 1986; 3 Suppl 2():S137-41. PubMed ID: 3598154
[TBL] [Abstract][Full Text] [Related]
34. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
Schalm SW; Heytink RA; Van Buuren HR; De Man RA
J Hepatol; 1986; 3 Suppl 2():S189-92. PubMed ID: 3598156
[TBL] [Abstract][Full Text] [Related]
35. Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol.
Kanai K; Morioka S; Nakajima T; Ishii H; Tamakoshi K; Matsuda H; Matsumoto M; Mizushima N; Takehira Y
Gastroenterol Jpn; 1988 Feb; 23(1):44-8. PubMed ID: 3350278
[TBL] [Abstract][Full Text] [Related]
36. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
[TBL] [Abstract][Full Text] [Related]
37. A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patients.
Alexander GJ; Fagan EA; Guarner P; Rolando N; Brahm J; Eddleston AL; Williams R
J Hepatol; 1986; 3 Suppl 2():S183-8. PubMed ID: 3298406
[TBL] [Abstract][Full Text] [Related]
38. Treatment of chronic delta hepatitis with alpha-2 recombinant interferon.
Rizzetto M; Rosina F; Saracco G; Bellando PC; Actis GC; Bonino F; Smedile A; Trinchero P; Sansalvadore F; Pintus C
J Hepatol; 1986; 3 Suppl 2():S229-33. PubMed ID: 3298410
[TBL] [Abstract][Full Text] [Related]
39. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
[TBL] [Abstract][Full Text] [Related]
40. Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B.
Fattovich G; Brollo L; Boscaro S; Pontisso P; Giustina G; Criscuolo D; Maladorno D; Alberti A; Realdi G; Ruol A
J Hepatol; 1989 Nov; 9(3):331-7. PubMed ID: 2691568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
